Modern Healthcare - - NEWS MAKERS -

Michael Rousseau will be­come pres­i­dent and CEO of med­i­cal-de­vice Daniel maker St. Jude Med­i­cal when Starks re­tires at the end of the year. Rousseau, 59, will take the helm on Jan. 1, re­plac­ing Starks, who will re­tain the ti­tle of ex­ec­u­tive board chair­man at the St. Paul, Minn.-based com­pany.

Starks pointed to St. Jude’s atrial fib­ril­la­tion port­fo­lio, Car­dio MEMS heart fail­ure mon­i­tor and neu­ro­mod­u­la­tion prod­ucts for chronic pain as driv­ers of growth dur­ing his 11-year ten­ure.

Rousseau joined St. Jude in 1999 as se­nior VP of car­diac rhythm man­age­ment global mar­ket­ing, which later was com­bined with the di­vi­sion’s sales team. In Jan­uary 2008, he was pro­moted to group pres­i­dent and over­saw the com­pany’s four prod­uct di­vi­sions be­fore be­ing named COO in 2014.

Newspapers in English

Newspapers from USA

© PressReader. All rights reserved.